Novo Next Generation Shot Helps Patients Lose 23% of Weight

Novo Nordisk A/S’s experimental shot CagriSema helped patients lose an average of 22.7% of their weight in a study that will help determine whether the drugmaker can continue to dominate the obesity drug market it helped establish.

Source link